Disclosed is a carrier for transporting a compound to an intestinal tract-related lymphoid tissue with efficiency without undergoing degradation or digestion. The carrier comprises a spherical cell of a gastric-mucosal-damage-inducing spiral bacterium. The carrier is preferably administered orally. When an antigen is added to the carrier and the mixture is administered orally, a local or systemic immune reaction against the antigen can be induced.
